| Stage1 (Anemia) | Stage2 (Fever) | Stage3 (Hematuria) | Discharge | Follow-up | Normal range |
---|---|---|---|---|---|---|
Complete blood cell count | Â | Â | Â | Â | Â | Â |
WBC count (109/L) | 3.71 | 2.91 | 8.53 | 7.63 | 8.31 | 5–12 |
Absolute neutrophil count (109/L) | 2.15 | 1.92 | 6.03 | 5.02 | 4.54 | 1.8–6.3 |
Hemoglobin (g/l) | 72 | 56 | 102 | 114 | 111 | 110–160 |
Platelet count (109/L) | 152 | 153 | 196 | 168 | 230 | 100–400 |
Chemistry | Â | Â | Â | Â | Â | Â |
Creatinine (umol/l) | 68 | 66.2 | 78 | 65 | 80 | 44–133 |
BUN (mmol/l) | 9.48 | 3.82 | 21 | 19.6 | 5.7 | 2.9–7.14 |
Uric acid (umol/l) | 239.7 | 279 | 334 | 330 | 187 | 155–357 |
Urinary analysis | Â | Â | Â | Â | Â | Â |
protein | Negative | Negative | + | Â | Negative | Â |
Leukocyte esterase | Negative | Negative | Negative | Â | Negative | Â |
Glucose | Negative | Negative | +- | Â | +- | Â |
Occult blood | Negative | Negative | +++ | Â | + | Â |
RBC (/HP) | 0 | 0 | +++ | Â | Â | 0 |
WBC (/HP) | 0 | 0–1 | 0 |  |  | 0–3 |
24-h urine protein (mg/day) | Â | Â | 1573.11 | Â | Â | 0-150 |
Urine culture | Â | Â | Proteus mirabilis | Negative | Â | Â |
Immune serologies | Â | Â | Â | Â | Â | Â |
C1q | Â | 2.3 | 5.32 | Â | Â | <10 |
ANA (1: 80) | Â | Positive | Negative | Â | Â | Â |
ANA (1: 160) | Â | Positive | Negative | Â | Â | Â |
ANA (1: 320) | Â | Negative | Negative | Â | Â | Â |
Anti-dsDNA | Â | Positive | Negative | Â | Â | Â |
Anti-SM | Â | Negative | Â | Â | Â | Â |
C3 (g/l) |  | 0.55 | 0.46 |  |  | 0.79–1.52 |
C4 (g/l) |  | 0.18 | 0.12 |  |  | 0.16–0.38 |
ESR (mm/h) |  | 9 |  |  |  | 0–20 |
Anemia-related tests | Â | Â | Â | Â | Â | Â |
Serum vitamin B12 (pg/ml) | 554 |  |  |  |  | 187–883 |
Olic acid (ng/ml) | >20 |  |  |  |  | 3.1–20.5 |
Thalassemia gene test | Negative | Â | Â | Â | Â | Â |
Sucrose hemolysis test | Negative | Â | Â | Â | Â | Â |
Direct anti-human globulin (IgG) test | Negative | Â | Â | Â | Â | Â |
Direct anti-human globulin (C3) test | Negative | Â | Â | Â | Â | Â |
TRF (g/l) |  | 1.03 |  |  |  | 2.02–3.36 |
Infectious tests | Â | Â | Â | Â | Â | Â |
CRP (mg/l) |  | 2.07 |  |  |  | 0–8 |
PCT (ng/ml) | Â | 0.126 | 0.058 | Â | Â | 0-0.05 |
G text | Â | 78.5 | <37.5 | Â | Â | <70 |
GM text | Â | 0.02 | Â | Â | Â | <0.5 |
Blood culture | Â | Negative | Â | Â | Â | Â |
Bone marrow culture | Â | Negative | Â | Â | Â | Â |
Virus DNA quantification | Â | Â | Â | Â | Â | Â |
CMV-DNA (copies/ml) | Negative | Negative | 142 | Â | Â | <500 |
B19-DNA (ct) | 7.21 | 4.57 | 31.3 | Â | Â | >38 |
JCV-DNA (copies/ml) | Negative |  |  |  |  | <2.0E + 03 |
BKV-DNA (copies/ml) | Negative |  | Negative |  |  | <2.0E + 03 |
EBV-DNA(copies/ml) | 22.66 | 1.27E + 03 | Negative | 393.2 |  | <500 |
 EBV-DNA in B cells (copies/105cells) |  | 18.21 |  |  |  |  |
 EBV-DNA in T cells (copies/105cells) |  | 45.3 |  |  |  |  |
 EBV-DNA in NK cells (copies/105cells) |  | Negative |  |  |  |  |
HLH-specific tests | Â | Â | Â | Â | Â | Â |
Fibrinogen (g/l) |  | 1.94 | 1.76 |  |  | 2–4 |
Triglyceride (mmol/l) | Â | 1.91 | 0.73 | Â | Â | <1.71 |
Ferritin (ng/l) | 332.9 | 622.9 | 99.71 |  |  | 4.63–204 |
Soluble interleukin-2 receptor (u/ml) |  | 2903 |  |  |  | 223–710 |
Natural killer cell activity (pg/ml) | Â | 2.55% | Â | Â | Â | Â |
Genetic testing for HLH | Â | Negative | Â | Â | Â | Â |